Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.426657912380658.
The log-likelihood improved by 3.157.
Iteration 2 of at most 500:
Optimizing with step length 0.649389098276578.
The log-likelihood improved by 2.248.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.8816.
Step length converged once. Increasing MCMC sample size.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.09703.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       4       21     1183     1052      816      346      391      379 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     275      215      134       76       47       27       17       11 
degree16 degree17 degree20 
       4        1        1 
1 
disease_progression 
H-positive risk:  902 859 124 892 448 122 863 415 116 71 131 57 
H-negative risk:  859 902 863 892 415 448 122 124 131 116 57 71 
New BC onsets:  1
BC status:  4999 1 
BC subtype:  4999 1 

clinical_engagement 
diagnosis 
demography 
78 new agents 
2 
disease_progression 
H-positive risk:  902 862 124 899 447 125 863 411 114 70 127 56 
H-negative risk:  862 902 863 899 411 447 125 124 127 114 56 70 
New BC onsets:  2
BC status:  4998 2 
BC subtype:  4998 1 1 

clinical_engagement 
diagnosis 
demography 
56 new agents 
3 
disease_progression 
H-positive risk:  904 861 123 899 441 131 865 408 116 71 125 56 
H-negative risk:  861 904 865 899 408 441 131 123 125 116 56 71 
New BC onsets:  3
BC status:  4997 3 
BC subtype:  4997 2 1 

clinical_engagement 
diagnosis 
demography 
57 new agents 
4 
disease_progression 
H-positive risk:  908 867 124 906 443 132 855 404 117 67 122 55 
H-negative risk:  867 908 855 906 404 443 132 124 122 117 55 67 
New BC onsets:  4
BC status:  4996 4 
BC subtype:  4996 3 1 

clinical_engagement 
diagnosis 
demography 
57 new agents 
5 
disease_progression 
H-positive risk:  912 874 126 899 440 133 848 409 116 66 122 55 
H-negative risk:  874 912 848 899 409 440 133 126 122 116 55 66 
New BC onsets:  6
BC status:  4994 6 
BC subtype:  4994 5 1 

clinical_engagement 
diagnosis 
demography 
54 new agents 
6 
disease_progression 
H-positive risk:  920 878 124 892 439 134 853 402 116 64 122 56 
H-negative risk:  878 920 853 892 402 439 134 124 122 116 56 64 
New BC onsets:  10
BC status:  4990 10 
BC subtype:  4990 9 1 

clinical_engagement 
diagnosis 
demography 
58 new agents 
7 
disease_progression 
H-positive risk:  926 889 124 892 431 132 851 393 116 67 122 57 
H-negative risk:  889 926 851 892 393 431 132 124 122 116 57 67 
New BC onsets:  11
BC status:  4989 11 
BC subtype:  4989 9 2 

clinical_engagement 
diagnosis 
demography 
54 new agents 
8 
disease_progression 
H-positive risk:  938 887 125 899 432 131 846 384 115 65 122 56 
H-negative risk:  887 938 846 899 384 432 131 125 122 115 56 65 
New BC onsets:  11
BC status:  4989 11 
BC subtype:  4989 9 2 

clinical_engagement 
diagnosis 
demography 
48 new agents 
9 
disease_progression 
H-positive risk:  947 891 128 897 426 130 842 385 114 64 121 55 
H-negative risk:  891 947 842 897 385 426 130 128 121 114 55 64 
New BC onsets:  12
BC status:  4988 12 
BC subtype:  4988 10 2 

clinical_engagement 
diagnosis 
demography 
53 new agents 
10 
disease_progression 
H-positive risk:  952 896 129 895 424 128 846 383 114 61 117 55 
H-negative risk:  896 952 846 895 383 424 128 129 117 114 55 61 
New BC onsets:  15
BC status:  4985 15 
BC subtype:  4985 13 2 

clinical_engagement 
diagnosis 
demography 
40 new agents 
11 
disease_progression 
H-positive risk:  959 901 130 892 420 130 849 377 113 60 114 55 
H-negative risk:  901 959 849 892 377 420 130 130 114 113 55 60 
New BC onsets:  19
BC status:  4981 19 
BC subtype:  4981 16 3 

clinical_engagement 
diagnosis 
demography 
62 new agents 
12 
disease_progression 
H-positive risk:  967 904 131 890 414 129 851 373 116 59 111 55 
H-negative risk:  904 967 851 890 373 414 129 131 111 116 55 59 
New BC onsets:  20
BC status:  4980 20 
BC subtype:  4980 17 3 

clinical_engagement 
diagnosis 
demography 
70 new agents 
13 
disease_progression 
H-positive risk:  882 829 126 964 414 118 943 367 128 56 117 56 
H-negative risk:  829 882 943 964 367 414 118 126 117 128 56 56 
New BC onsets:  22
BC status:  4978 22 
BC subtype:  4978 18 4 

clinical_engagement 
diagnosis 
demography 
236 new agents 
14 
disease_progression 
H-positive risk:  907 867 133 923 441 122 911 348 122 62 111 53 
H-negative risk:  867 907 911 923 348 441 122 133 111 122 53 62 
New BC onsets:  25
BC status:  4975 25 
BC subtype:  4975 22 3 

clinical_engagement 
diagnosis 
demography 
55 new agents 
15 
disease_progression 
H-positive risk:  905 869 131 923 447 121 907 346 124 60 113 54 
H-negative risk:  869 905 907 923 346 447 121 131 113 124 54 60 
New BC onsets:  27
BC status:  4973 27 
BC subtype:  4973 23 4 

clinical_engagement 
diagnosis 
demography 
61 new agents 
16 
disease_progression 
H-positive risk:  916 872 130 920 447 123 909 340 121 59 111 52 
H-negative risk:  872 916 909 920 340 447 123 130 111 121 52 59 
New BC onsets:  32
BC status:  4968 32 
BC subtype:  4968 27 5 

clinical_engagement 
diagnosis 
demography 
65 new agents 
17 
disease_progression 
H-positive risk:  922 878 130 924 439 125 910 335 117 59 110 51 
H-negative risk:  878 922 910 924 335 439 125 130 110 117 51 59 
New BC onsets:  32
BC status:  4968 32 
BC subtype:  4968 27 5 

clinical_engagement 
diagnosis 
demography 
67 new agents 
18 
disease_progression 
H-positive risk:  921 876 130 926 435 129 910 337 118 58 108 52 
H-negative risk:  876 921 910 926 337 435 129 130 108 118 52 58 
New BC onsets:  34
BC status:  4966 34 
BC subtype:  4966 29 5 

clinical_engagement 
diagnosis 
demography 
48 new agents 
19 
disease_progression 
H-positive risk:  931 876 131 923 433 130 908 337 117 58 104 52 
H-negative risk:  876 931 908 923 337 433 130 131 104 117 52 58 
New BC onsets:  36
BC status:  4964 36 
BC subtype:  4964 31 5 

clinical_engagement 
diagnosis 
demography 
52 new agents 
20 
disease_progression 
H-positive risk:  929 881 131 931 426 135 901 334 117 57 102 56 
H-negative risk:  881 929 901 931 334 426 135 131 102 117 56 57 
New BC onsets:  38
BC status:  4962 38 
BC subtype:  4962 33 5 

clinical_engagement 
diagnosis 
demography 
65 new agents 
21 
disease_progression 
H-positive risk:  935 885 132 928 427 134 902 327 118 56 102 54 
H-negative risk:  885 935 902 928 327 427 134 132 102 118 54 56 
New BC onsets:  39
BC status:  4961 39 
BC subtype:  4961 33 6 

clinical_engagement 
diagnosis 
demography 
63 new agents 
22 
disease_progression 
H-positive risk:  938 887 130 927 425 133 900 326 118 56 105 55 
H-negative risk:  887 938 900 927 326 425 133 130 105 118 55 56 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 39 6 

clinical_engagement 
diagnosis 
demography 
67 new agents 
23 
disease_progression 
H-positive risk:  941 896 127 919 420 133 904 327 115 55 108 55 
H-negative risk:  896 941 904 919 327 420 133 127 108 115 55 55 
New BC onsets:  46
BC status:  4954 46 
BC subtype:  4954 40 6 

clinical_engagement 
diagnosis 
demography 
60 new agents 
24 
disease_progression 
H-positive risk:  945 900 130 921 420 133 898 325 113 54 107 54 
H-negative risk:  900 945 898 921 325 420 133 130 107 113 54 54 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 39 6 

clinical_engagement 
diagnosis 
demography 
64 new agents 
25 
disease_progression 
H-positive risk:  883 823 120 989 419 122 978 322 123 52 117 52 
H-negative risk:  823 883 978 989 322 419 122 120 117 123 52 52 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 41 6 

clinical_engagement 
diagnosis 
demography 
182 new agents 
26 
disease_progression 
H-positive risk:  894 845 122 937 440 124 927 369 120 55 111 56 
H-negative risk:  845 894 927 937 369 440 124 122 111 120 56 55 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 40 7 

clinical_engagement 
diagnosis 
demography 
80 new agents 
27 
disease_progression 
H-positive risk:  904 850 120 934 438 123 922 371 118 52 113 55 
H-negative risk:  850 904 922 934 371 438 123 120 113 118 55 52 
New BC onsets:  46
BC status:  4954 46 
BC subtype:  4954 39 7 

clinical_engagement 
diagnosis 
demography 
55 new agents 
28 
disease_progression 
H-positive risk:  903 853 120 936 430 123 923 370 120 53 115 54 
H-negative risk:  853 903 923 936 370 430 123 120 115 120 54 53 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 40 7 

clinical_engagement 
diagnosis 
demography 
61 new agents 
29 
disease_progression 
H-positive risk:  908 864 121 936 425 120 920 365 118 54 114 55 
H-negative risk:  864 908 920 936 365 425 120 121 114 118 55 54 
New BC onsets:  49
BC status:  4951 49 
BC subtype:  4951 42 7 

clinical_engagement 
diagnosis 
demography 
61 new agents 
30 
disease_progression 
H-positive risk:  917 859 123 931 420 119 921 363 122 54 116 55 
H-negative risk:  859 917 921 931 363 420 119 123 116 122 55 54 
New BC onsets:  51
BC status:  4949 51 
BC subtype:  4949 43 8 

clinical_engagement 
diagnosis 
demography 
52 new agents 
31 
disease_progression 
H-positive risk:  913 861 123 938 419 118 924 362 119 53 117 53 
H-negative risk:  861 913 924 938 362 419 118 123 117 119 53 53 
New BC onsets:  54
BC status:  4946 54 
BC subtype:  4946 46 8 

clinical_engagement 
diagnosis 
demography 
58 new agents 
32 
disease_progression 
H-positive risk:  920 860 123 939 413 118 922 363 121 52 120 49 
H-negative risk:  860 920 922 939 363 413 118 123 120 121 49 52 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 50 8 

clinical_engagement 
diagnosis 
demography 
77 new agents 
33 
disease_progression 
H-positive risk:  920 867 121 939 404 118 921 370 124 52 118 46 
H-negative risk:  867 920 921 939 370 404 118 121 118 124 46 52 
New BC onsets:  59
BC status:  4941 59 
BC subtype:  4941 52 7 

clinical_engagement 
diagnosis 
demography 
51 new agents 
34 
disease_progression 
H-positive risk:  919 868 122 941 403 119 921 369 122 52 118 46 
H-negative risk:  868 919 921 941 369 403 119 122 118 122 46 52 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 55 7 

clinical_engagement 
diagnosis 
demography 
60 new agents 
35 
disease_progression 
H-positive risk:  920 870 124 946 396 120 916 367 121 52 121 47 
H-negative risk:  870 920 916 946 367 396 120 124 121 121 47 52 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 55 7 

clinical_engagement 
diagnosis 
demography 
59 new agents 
36 
disease_progression 
H-positive risk:  922 874 124 936 400 119 914 367 122 53 122 47 
H-negative risk:  874 922 914 936 367 400 119 124 122 122 47 53 
New BC onsets:  61
BC status:  4939 61 
BC subtype:  4939 55 6 

clinical_engagement 
diagnosis 
demography 
58 new agents 
37 
disease_progression 
H-positive risk:  849 813 109 1001 400 109 984 368 129 56 136 46 
H-negative risk:  813 849 984 1001 368 400 109 109 136 129 46 56 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 56 6 

clinical_engagement 
diagnosis 
demography 
142 new agents 
38 
disease_progression 
H-positive risk:  863 827 109 978 417 109 946 393 128 49 132 49 
H-negative risk:  827 863 946 978 393 417 109 109 132 128 49 49 
New BC onsets:  66
BC status:  4934 66 
BC subtype:  4934 60 6 

clinical_engagement 
diagnosis 
demography 
59 new agents 
39 
disease_progression 
H-positive risk:  869 831 110 973 417 110 948 381 129 49 133 50 
H-negative risk:  831 869 948 973 381 417 110 110 133 129 50 49 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 63 5 

clinical_engagement 
diagnosis 
demography 
60 new agents 
40 
disease_progression 
H-positive risk:  868 833 113 972 414 113 950 376 130 48 132 51 
H-negative risk:  833 868 950 972 376 414 113 113 132 130 51 48 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 65 5 

clinical_engagement 
diagnosis 
demography 
77 new agents 
41 
disease_progression 
H-positive risk:  875 840 115 968 409 115 943 374 130 48 132 51 
H-negative risk:  840 875 943 968 374 409 115 115 132 130 51 48 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 68 6 

clinical_engagement 
diagnosis 
demography 
58 new agents 
42 
disease_progression 
H-positive risk:  877 847 114 969 405 117 942 368 130 48 133 50 
H-negative risk:  847 877 942 969 368 405 117 114 133 130 50 48 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 69 6 

clinical_engagement 
diagnosis 
demography 
73 new agents 
43 
disease_progression 
H-positive risk:  882 851 114 968 399 122 936 362 130 50 134 52 
H-negative risk:  851 882 936 968 362 399 122 114 134 130 52 50 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 69 7 

clinical_engagement 
diagnosis 
demography 
47 new agents 
44 
disease_progression 
H-positive risk:  892 855 115 966 398 122 930 355 130 50 134 53 
H-negative risk:  855 892 930 966 355 398 122 115 134 130 53 50 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 73 8 

clinical_engagement 
diagnosis 
demography 
61 new agents 
45 
disease_progression 
H-positive risk:  889 860 115 968 398 122 929 354 128 50 134 53 
H-negative risk:  860 889 929 968 354 398 122 115 134 128 53 50 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 72 8 

clinical_engagement 
diagnosis 
demography 
56 new agents 
46 
disease_progression 
H-positive risk:  888 865 116 957 401 124 933 353 126 49 135 53 
H-negative risk:  865 888 933 957 353 401 124 116 135 126 53 49 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 74 8 

clinical_engagement 
diagnosis 
demography 
65 new agents 
47 
disease_progression 
H-positive risk:  889 863 117 955 403 123 927 357 127 50 136 53 
H-negative risk:  863 889 927 955 357 403 123 117 136 127 53 50 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 74 8 

clinical_engagement 
diagnosis 
demography 
70 new agents 
48 
disease_progression 
H-positive risk:  894 869 117 950 404 124 924 358 125 49 136 50 
H-negative risk:  869 894 924 950 358 404 124 117 136 125 50 49 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 72 8 

clinical_engagement 
diagnosis 
demography 
65 new agents 
49 
disease_progression 
H-positive risk:  826 804 114 1015 399 122 1009 349 129 49 136 48 
H-negative risk:  804 826 1009 1015 349 399 122 114 136 129 48 49 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 72 7 

clinical_engagement 
diagnosis 
demography 
134 new agents 
50 
disease_progression 
H-positive risk:  841 812 116 987 407 122 982 376 126 51 137 43 
H-negative risk:  812 841 982 987 376 407 122 116 137 126 43 51 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 72 6 

clinical_engagement 
diagnosis 
demography 
75 new agents 
51 
disease_progression 
H-positive risk:  849 812 117 978 403 120 982 377 127 54 138 43 
H-negative risk:  812 849 982 978 377 403 120 117 138 127 43 54 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 74 5 

clinical_engagement 
diagnosis 
demography 
61 new agents 
52 
disease_progression 
H-positive risk:  850 810 119 981 398 120 988 374 127 54 136 43 
H-negative risk:  810 850 988 981 374 398 120 119 136 127 43 54 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 75 6 

clinical_engagement 
diagnosis 
demography 
73 new agents 
53 
disease_progression 
H-positive risk:  851 813 119 985 392 120 991 370 131 54 134 40 
H-negative risk:  813 851 991 985 370 392 120 119 134 131 40 54 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 77 7 

clinical_engagement 
diagnosis 
demography 
76 new agents 
54 
disease_progression 
H-positive risk:  843 821 120 981 390 120 993 373 136 51 133 39 
H-negative risk:  821 843 993 981 373 390 120 120 133 136 39 51 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 79 7 

clinical_engagement 
diagnosis 
demography 
64 new agents 
55 
disease_progression 
H-positive risk:  849 819 120 980 383 119 983 384 138 49 137 39 
H-negative risk:  819 849 983 980 384 383 119 120 137 138 39 49 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 82 7 

clinical_engagement 
diagnosis 
demography 
73 new agents 
56 
disease_progression 
H-positive risk:  854 824 122 973 380 118 981 388 138 48 136 38 
H-negative risk:  824 854 981 973 388 380 118 122 136 138 38 48 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 83 7 

clinical_engagement 
diagnosis 
demography 
68 new agents 
57 
disease_progression 
H-positive risk:  861 820 121 974 375 118 985 386 137 49 135 39 
H-negative risk:  820 861 985 974 386 375 118 121 135 137 39 49 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 83 7 

clinical_engagement 
diagnosis 
demography 
70 new agents 
58 
disease_progression 
H-positive risk:  866 826 120 972 371 120 984 380 139 48 135 39 
H-negative risk:  826 866 984 972 380 371 120 120 135 139 39 48 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 87 7 

clinical_engagement 
diagnosis 
demography 
68 new agents 
59 
disease_progression 
H-positive risk:  869 832 120 974 366 122 983 370 137 50 135 42 
H-negative risk:  832 869 983 974 370 366 122 120 135 137 42 50 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 86 7 

clinical_engagement 
diagnosis 
demography 
64 new agents 
60 
disease_progression 
H-positive risk:  876 832 121 969 364 120 985 368 136 53 135 41 
H-negative risk:  832 876 985 969 368 364 120 121 135 136 41 53 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 88 7 

clinical_engagement 
diagnosis 
demography 
63 new agents 
61 
disease_progression 
H-positive risk:  827 775 119 1024 361 117 1032 367 142 54 142 40 
H-negative risk:  775 827 1032 1024 367 361 117 119 142 142 40 54 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 86 7 

clinical_engagement 
diagnosis 
demography 
132 new agents 
62 
disease_progression 
H-positive risk:  832 778 122 1003 369 121 1033 368 144 51 139 40 
H-negative risk:  778 832 1033 1003 368 369 121 122 139 144 40 51 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 83 7 

clinical_engagement 
diagnosis 
demography 
77 new agents 
63 
disease_progression 
H-positive risk:  844 776 121 1000 369 121 1032 371 142 49 139 36 
H-negative risk:  776 844 1032 1000 371 369 121 121 139 142 36 49 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 80 6 

clinical_engagement 
diagnosis 
demography 
66 new agents 
64 
disease_progression 
H-positive risk:  850 777 122 1001 364 120 1030 370 142 49 136 39 
H-negative risk:  777 850 1030 1001 370 364 120 122 136 142 39 49 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 83 6 

clinical_engagement 
diagnosis 
demography 
64 new agents 
65 
disease_progression 
H-positive risk:  855 782 121 994 363 121 1026 368 144 48 138 40 
H-negative risk:  782 855 1026 994 368 363 121 121 138 144 40 48 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 84 8 

clinical_engagement 
diagnosis 
demography 
79 new agents 
66 
disease_progression 
H-positive risk:  853 794 126 991 357 121 1019 366 145 49 138 41 
H-negative risk:  794 853 1019 991 366 357 121 126 138 145 41 49 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 85 9 

clinical_engagement 
diagnosis 
demography 
78 new agents 
67 
disease_progression 
H-positive risk:  854 804 126 991 355 122 1016 354 148 50 139 41 
H-negative risk:  804 854 1016 991 354 355 122 126 139 148 41 50 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 85 9 

clinical_engagement 
diagnosis 
demography 
62 new agents 
68 
disease_progression 
H-positive risk:  855 809 128 984 358 120 1017 351 149 49 139 41 
H-negative risk:  809 855 1017 984 351 358 120 128 139 149 41 49 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 86 9 

clinical_engagement 
diagnosis 
demography 
60 new agents 
69 
disease_progression 
H-positive risk:  852 814 127 986 352 121 1023 351 146 47 138 43 
H-negative risk:  814 852 1023 986 351 352 121 127 138 146 43 47 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 88 9 

clinical_engagement 
diagnosis 
demography 
71 new agents 
70 
disease_progression 
H-positive risk:  860 811 128 986 349 124 1025 345 144 47 139 42 
H-negative risk:  811 860 1025 986 345 349 124 128 139 144 42 47 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 88 9 

clinical_engagement 
diagnosis 
demography 
70 new agents 
71 
disease_progression 
H-positive risk:  858 812 127 992 345 124 1021 348 145 48 139 41 
H-negative risk:  812 858 1021 992 348 345 124 127 139 145 41 48 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 85 9 

clinical_engagement 
diagnosis 
demography 
56 new agents 
72 
disease_progression 
H-positive risk:  855 811 128 994 342 124 1022 346 147 49 142 40 
H-negative risk:  811 855 1022 994 346 342 124 128 142 147 40 49 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 85 10 

clinical_engagement 
diagnosis 
demography 
60 new agents 
73 
disease_progression 
H-positive risk:  822 766 117 1036 343 122 1053 345 152 48 154 42 
H-negative risk:  766 822 1053 1036 345 343 122 117 154 152 42 48 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 85 12 

clinical_engagement 
diagnosis 
demography 
111 new agents 
74 
disease_progression 
H-positive risk:  831 764 120 1017 347 119 1045 361 149 51 151 45 
H-negative risk:  764 831 1045 1017 361 347 119 120 151 149 45 51 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 83 15 

clinical_engagement 
diagnosis 
demography 
78 new agents 
75 
disease_progression 
H-positive risk:  830 764 121 1021 347 121 1043 368 144 49 147 45 
H-negative risk:  764 830 1043 1021 368 347 121 121 147 144 45 49 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 79 17 

clinical_engagement 
diagnosis 
demography 
69 new agents 
76 
disease_progression 
H-positive risk:  839 770 118 1016 347 121 1046 361 144 48 148 42 
H-negative risk:  770 839 1046 1016 361 347 121 118 148 144 42 48 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 76 17 

clinical_engagement 
diagnosis 
demography 
53 new agents 
77 
disease_progression 
H-positive risk:  843 762 121 1012 347 118 1045 364 146 50 150 42 
H-negative risk:  762 843 1045 1012 364 347 118 121 150 146 42 50 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 79 17 

clinical_engagement 
diagnosis 
demography 
68 new agents 
78 
disease_progression 
H-positive risk:  843 765 121 1017 345 118 1042 363 146 51 148 41 
H-negative risk:  765 843 1042 1017 363 345 118 121 148 146 41 51 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 81 18 

clinical_engagement 
diagnosis 
demography 
54 new agents 
79 
disease_progression 
H-positive risk:  833 763 120 1013 349 117 1048 369 145 51 148 44 
H-negative risk:  763 833 1048 1013 369 349 117 120 148 145 44 51 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
62 new agents 
80 
disease_progression 
H-positive risk:  831 763 119 1010 353 118 1050 369 146 51 147 43 
H-negative risk:  763 831 1050 1010 369 353 118 119 147 146 43 51 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 85 18 

clinical_engagement 
diagnosis 
demography 
55 new agents 
81 
disease_progression 
H-positive risk:  830 766 120 999 353 118 1053 374 146 50 148 43 
H-negative risk:  766 830 1053 999 374 353 118 120 148 146 43 50 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
70 new agents 
82 
disease_progression 
H-positive risk:  839 771 121 1000 345 117 1049 373 145 51 146 43 
H-negative risk:  771 839 1049 1000 373 345 117 121 146 145 43 51 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 80 18 

clinical_engagement 
diagnosis 
demography 
80 new agents 
83 
disease_progression 
H-positive risk:  838 771 122 1001 343 119 1048 374 143 48 150 43 
H-negative risk:  771 838 1048 1001 374 343 119 122 150 143 43 48 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 80 17 

clinical_engagement 
diagnosis 
demography 
68 new agents 
84 
disease_progression 
H-positive risk:  844 774 120 1000 344 119 1043 368 139 52 154 43 
H-negative risk:  774 844 1043 1000 368 344 119 120 154 139 43 52 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 80 18 

clinical_engagement 
diagnosis 
demography 
59 new agents 
85 
disease_progression 
H-positive risk:  781 727 116 1050 344 108 1108 364 152 50 155 45 
H-negative risk:  727 781 1108 1050 364 344 108 116 155 152 45 50 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 80 18 

clinical_engagement 
diagnosis 
demography 
107 new agents 
86 
disease_progression 
H-positive risk:  777 733 112 1039 356 106 1093 372 152 54 158 48 
H-negative risk:  733 777 1093 1039 372 356 106 112 158 152 48 54 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
87 
disease_progression 
H-positive risk:  766 736 111 1037 363 103 1092 376 156 52 156 52 
H-negative risk:  736 766 1092 1037 376 363 103 111 156 156 52 52 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
65 new agents 
88 
disease_progression 
H-positive risk:  762 735 111 1038 364 103 1090 385 156 48 155 53 
H-negative risk:  735 762 1090 1038 385 364 103 111 155 156 53 48 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
65 new agents 
89 
disease_progression 
H-positive risk:  762 733 110 1039 365 104 1095 383 153 49 156 51 
H-negative risk:  733 762 1095 1039 383 365 104 110 156 153 51 49 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
63 new agents 
90 
disease_progression 
H-positive risk:  757 741 110 1034 363 102 1100 375 157 50 161 50 
H-negative risk:  741 757 1100 1034 375 363 102 110 161 157 50 50 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 73 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
91 
disease_progression 
H-positive risk:  755 745 111 1032 364 103 1104 370 158 48 159 51 
H-negative risk:  745 755 1104 1032 370 364 103 111 159 158 51 48 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 73 19 

clinical_engagement 
diagnosis 
demography 
66 new agents 
92 
disease_progression 
H-positive risk:  757 746 112 1037 360 102 1104 367 153 52 159 51 
H-negative risk:  746 757 1104 1037 367 360 102 112 159 153 51 52 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 69 19 

clinical_engagement 
diagnosis 
demography 
69 new agents 
93 
disease_progression 
H-positive risk:  757 749 111 1042 358 102 1099 368 152 53 157 52 
H-negative risk:  749 757 1099 1042 368 358 102 111 157 152 52 53 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 68 21 

clinical_engagement 
diagnosis 
demography 
84 new agents 
94 
disease_progression 
H-positive risk:  771 752 110 1040 354 97 1097 365 152 53 158 51 
H-negative risk:  752 771 1097 1040 365 354 97 110 158 152 51 53 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 69 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
95 
disease_progression 
H-positive risk:  766 753 112 1037 353 95 1098 369 154 56 158 49 
H-negative risk:  753 766 1098 1037 369 353 95 112 158 154 49 56 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 66 22 

clinical_engagement 
diagnosis 
demography 
84 new agents 
96 
disease_progression 
H-positive risk:  776 756 115 1043 341 97 1104 353 150 59 153 53 
H-negative risk:  756 776 1104 1043 353 341 97 115 153 150 53 59 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 67 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
97 
disease_progression 
H-positive risk:  731 724 112 1071 343 86 1150 356 161 56 155 55 
H-negative risk:  724 731 1150 1071 356 343 86 112 155 161 55 56 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 69 20 

clinical_engagement 
diagnosis 
demography 
96 new agents 
98 
disease_progression 
H-positive risk:  734 723 113 1068 353 86 1140 358 160 54 151 60 
H-negative risk:  723 734 1140 1068 358 353 86 113 151 160 60 54 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 72 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
99 
disease_progression 
H-positive risk:  731 732 113 1070 359 85 1142 346 158 58 148 58 
H-negative risk:  732 731 1142 1070 346 359 85 113 148 158 58 58 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 76 19 

clinical_engagement 
diagnosis 
demography 
61 new agents 
100 
disease_progression 
H-positive risk:  725 734 114 1073 361 83 1143 348 157 56 148 58 
H-negative risk:  734 725 1143 1073 348 361 83 114 148 157 58 56 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 75 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
101 
disease_progression 
H-positive risk:  734 727 112 1078 360 82 1140 347 157 57 148 58 
H-negative risk:  727 734 1140 1078 347 360 82 112 148 157 58 57 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 73 19 

clinical_engagement 
diagnosis 
demography 
68 new agents 
102 
disease_progression 
H-positive risk:  741 732 113 1077 356 83 1133 344 157 57 148 59 
H-negative risk:  732 741 1133 1077 344 356 83 113 148 157 59 57 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 73 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
103 
disease_progression 
H-positive risk:  739 738 111 1075 354 82 1131 351 159 54 149 57 
H-negative risk:  738 739 1131 1075 351 354 82 111 149 159 57 54 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 71 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
104 
disease_progression 
H-positive risk:  747 747 111 1069 349 82 1127 347 159 55 150 57 
H-negative risk:  747 747 1127 1069 347 349 82 111 150 159 57 55 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 71 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
105 
disease_progression 
H-positive risk:  744 739 111 1070 353 85 1132 343 159 56 149 59 
H-negative risk:  739 744 1132 1070 343 353 85 111 149 159 59 56 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 69 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
106 
disease_progression 
H-positive risk:  748 737 113 1067 352 85 1131 344 158 56 147 62 
H-negative risk:  737 748 1131 1067 344 352 85 113 147 158 62 56 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 69 23 

clinical_engagement 
diagnosis 
demography 
62 new agents 
107 
disease_progression 
H-positive risk:  753 739 112 1063 353 84 1130 339 161 54 149 63 
H-negative risk:  739 753 1130 1063 339 353 84 112 149 161 63 54 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 67 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
108 
disease_progression 
H-positive risk:  753 743 114 1059 353 88 1124 340 160 55 144 67 
H-negative risk:  743 753 1124 1059 340 353 88 114 144 160 67 55 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 68 21 

clinical_engagement 
diagnosis 
demography 
49 new agents 
109 
disease_progression 
H-positive risk:  698 699 107 1105 352 88 1177 338 163 54 147 72 
H-negative risk:  699 698 1177 1105 338 352 88 107 147 163 72 54 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 65 20 

clinical_engagement 
diagnosis 
demography 
93 new agents 
110 
disease_progression 
H-positive risk:  687 701 107 1101 352 89 1170 356 159 57 140 81 
H-negative risk:  701 687 1170 1101 356 352 89 107 140 159 81 57 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 64 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
111 
disease_progression 
H-positive risk:  679 704 106 1106 354 86 1175 354 156 58 141 81 
H-negative risk:  704 679 1175 1106 354 354 86 106 141 156 81 58 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 65 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
112 
disease_progression 
H-positive risk:  676 705 110 1110 346 85 1184 353 156 57 140 78 
H-negative risk:  705 676 1184 1110 353 346 85 110 140 156 78 57 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 62 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
113 
disease_progression 
H-positive risk:  675 701 110 1105 345 84 1184 360 157 61 144 74 
H-negative risk:  701 675 1184 1105 360 345 84 110 144 157 74 61 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 65 21 

clinical_engagement 
diagnosis 
demography 
81 new agents 
114 
disease_progression 
H-positive risk:  675 706 108 1117 340 83 1181 356 157 61 143 73 
H-negative risk:  706 675 1181 1117 356 340 83 108 143 157 73 61 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 66 22 

clinical_engagement 
diagnosis 
demography 
82 new agents 
115 
disease_progression 
H-positive risk:  668 705 111 1118 341 81 1190 357 155 61 141 72 
H-negative risk:  705 668 1190 1118 357 341 81 111 141 155 72 61 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 68 22 

clinical_engagement 
diagnosis 
demography 
67 new agents 
116 
disease_progression 
H-positive risk:  662 707 111 1116 343 82 1195 354 155 60 144 71 
H-negative risk:  707 662 1195 1116 354 343 82 111 144 155 71 60 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 67 23 

clinical_engagement 
diagnosis 
demography 
63 new agents 
117 
disease_progression 
H-positive risk:  661 713 111 1111 347 80 1198 351 154 60 144 70 
H-negative risk:  713 661 1198 1111 351 347 80 111 144 154 70 60 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 68 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
118 
disease_progression 
H-positive risk:  657 716 112 1108 347 81 1196 354 153 61 145 70 
H-negative risk:  716 657 1196 1108 354 347 81 112 145 153 70 61 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 70 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
119 
disease_progression 
H-positive risk:  659 720 114 1100 347 80 1200 356 151 59 146 68 
H-negative risk:  720 659 1200 1100 356 347 80 114 146 151 68 59 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 70 23 

clinical_engagement 
diagnosis 
demography 
63 new agents 
120 
disease_progression 
H-positive risk:  659 718 113 1086 352 81 1206 361 150 59 148 67 
H-negative risk:  718 659 1206 1086 361 352 81 113 148 150 67 59 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 69 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
121 
disease_progression 
H-positive risk:  621 674 108 1129 353 73 1251 358 157 59 151 66 
H-negative risk:  674 621 1251 1129 358 353 73 108 151 157 66 59 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 70 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
122 
disease_progression 
H-positive risk:  609 673 105 1117 364 73 1237 384 156 64 156 62 
H-negative risk:  673 609 1237 1117 384 364 73 105 156 156 62 64 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 71 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
123 
disease_progression 
H-positive risk:  611 669 104 1119 364 74 1231 387 159 65 153 64 
H-negative risk:  669 611 1231 1119 387 364 74 104 153 159 64 65 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 71 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
124 
disease_progression 
H-positive risk:  607 671 103 1119 369 74 1218 393 160 67 155 64 
H-negative risk:  671 607 1218 1119 393 369 74 103 155 160 64 67 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 70 21 

clinical_engagement 
diagnosis 
demography 
68 new agents 
125 
disease_progression 
H-positive risk:  616 674 103 1111 364 75 1217 392 163 66 156 63 
H-negative risk:  674 616 1217 1111 392 364 75 103 156 163 63 66 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 68 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
126 
disease_progression 
H-positive risk:  619 669 101 1115 368 76 1220 391 161 63 156 61 
H-negative risk:  669 619 1220 1115 391 368 76 101 156 161 61 63 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 67 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
127 
disease_progression 
H-positive risk:  624 674 101 1111 364 81 1220 387 160 59 156 63 
H-negative risk:  674 624 1220 1111 387 364 81 101 156 160 63 59 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 67 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
128 
disease_progression 
H-positive risk:  624 680 100 1104 362 81 1228 386 160 58 155 62 
H-negative risk:  680 624 1228 1104 386 362 81 100 155 160 62 58 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 66 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
129 
disease_progression 
H-positive risk:  625 680 100 1104 366 82 1231 382 161 60 150 59 
H-negative risk:  680 625 1231 1104 382 366 82 100 150 161 59 60 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 67 19 

clinical_engagement 
diagnosis 
demography 
79 new agents 
130 
disease_progression 
H-positive risk:  628 678 100 1102 369 82 1233 378 162 62 148 58 
H-negative risk:  678 628 1233 1102 378 369 82 100 148 162 58 62 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 69 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
131 
disease_progression 
H-positive risk:  632 677 95 1103 378 81 1228 376 162 61 149 58 
H-negative risk:  677 632 1228 1103 376 378 81 95 149 162 58 61 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 67 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
132 
disease_progression 
H-positive risk:  632 679 94 1118 365 81 1232 367 163 60 152 57 
H-negative risk:  679 632 1232 1118 367 365 81 94 152 163 57 60 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 69 19 

clinical_engagement 
diagnosis 
demography 
62 new agents 
133 
disease_progression 
H-positive risk:  628 674 93 1128 365 79 1233 365 161 62 156 56 
H-negative risk:  674 628 1233 1128 365 365 79 93 156 161 56 62 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 72 19 

clinical_engagement 
diagnosis 
demography 
92 new agents 
134 
disease_progression 
H-positive risk:  623 673 89 1118 375 79 1233 383 156 59 158 54 
H-negative risk:  673 623 1233 1118 383 375 79 89 158 156 54 59 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 70 19 

clinical_engagement 
diagnosis 
demography 
64 new agents 
135 
disease_progression 
H-positive risk:  627 676 87 1108 384 80 1223 383 157 61 162 52 
H-negative risk:  676 627 1223 1108 383 384 80 87 162 157 52 61 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 73 19 

clinical_engagement 
diagnosis 
demography 
84 new agents 
136 
disease_progression 
H-positive risk:  627 677 89 1099 387 82 1224 379 155 62 165 54 
H-negative risk:  677 627 1224 1099 379 387 82 89 165 155 54 62 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 69 19 

clinical_engagement 
diagnosis 
demography 
80 new agents 
137 
disease_progression 
H-positive risk:  624 673 90 1098 387 83 1230 379 157 61 165 53 
H-negative risk:  673 624 1230 1098 379 387 83 90 165 157 53 61 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 69 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
138 
disease_progression 
H-positive risk:  623 672 89 1097 389 86 1224 378 156 63 169 54 
H-negative risk:  672 623 1224 1097 378 389 86 89 169 156 54 63 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 66 20 

clinical_engagement 
diagnosis 
demography 
73 new agents 
139 
disease_progression 
H-positive risk:  622 678 89 1096 384 83 1220 385 158 64 168 53 
H-negative risk:  678 622 1220 1096 385 384 83 89 168 158 53 64 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 66 21 

clinical_engagement 
diagnosis 
demography 
69 new agents 
140 
disease_progression 
H-positive risk:  624 681 90 1089 390 81 1214 387 162 62 167 53 
H-negative risk:  681 624 1214 1089 387 390 81 90 167 162 53 62 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 66 22 

clinical_engagement 
diagnosis 
demography 
65 new agents 
141 
disease_progression 
H-positive risk:  625 673 89 1083 391 80 1225 386 165 62 168 53 
H-negative risk:  673 625 1225 1083 386 391 80 89 168 165 53 62 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 68 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
142 
disease_progression 
H-positive risk:  626 674 89 1084 391 79 1219 387 166 64 173 48 
H-negative risk:  674 626 1219 1084 387 391 79 89 173 166 48 64 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 68 25 

clinical_engagement 
diagnosis 
demography 
57 new agents 
143 
disease_progression 
H-positive risk:  625 671 88 1087 396 81 1212 392 167 60 172 49 
H-negative risk:  671 625 1212 1087 392 396 81 88 172 167 49 60 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 70 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
144 
disease_progression 
H-positive risk:  628 669 88 1097 394 81 1205 383 169 61 173 52 
H-negative risk:  669 628 1205 1097 383 394 81 88 173 169 52 61 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 72 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
145 
disease_progression 
H-positive risk:  622 666 89 1096 394 79 1203 392 172 61 171 55 
H-negative risk:  666 622 1203 1096 392 394 79 89 171 172 55 61 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 71 25 

clinical_engagement 
diagnosis 
demography 
86 new agents 
146 
disease_progression 
H-positive risk:  627 666 87 1094 401 74 1185 403 169 63 175 56 
H-negative risk:  666 627 1185 1094 403 401 74 87 175 169 56 63 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
102 new agents 
147 
disease_progression 
H-positive risk:  633 670 87 1095 402 73 1173 406 166 65 175 55 
H-negative risk:  670 633 1173 1095 406 402 73 87 175 166 55 65 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
148 
disease_progression 
H-positive risk:  630 679 86 1093 401 72 1170 408 167 65 172 57 
H-negative risk:  679 630 1170 1093 408 401 72 86 172 167 57 65 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
149 
disease_progression 
H-positive risk:  644 674 83 1092 407 71 1164 407 164 64 174 56 
H-negative risk:  674 644 1164 1092 407 407 71 83 174 164 56 64 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
150 
disease_progression 
H-positive risk:  642 664 82 1098 406 74 1163 408 164 65 177 57 
H-negative risk:  664 642 1163 1098 408 406 74 82 177 164 57 65 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 83 27 

clinical_engagement 
diagnosis 
demography 
91 new agents 
151 
disease_progression 
H-positive risk:  638 673 80 1107 400 77 1159 411 161 60 180 54 
H-negative risk:  673 638 1159 1107 411 400 77 80 180 161 54 60 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 82 27 

clinical_engagement 
diagnosis 
demography 
79 new agents 
152 
disease_progression 
H-positive risk:  633 671 81 1113 392 76 1165 413 162 62 176 56 
H-negative risk:  671 633 1165 1113 413 392 76 81 176 162 56 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 83 27 

clinical_engagement 
diagnosis 
demography 
64 new agents 
153 
disease_progression 
H-positive risk:  628 669 82 1111 394 75 1168 419 163 61 176 54 
H-negative risk:  669 628 1168 1111 419 394 75 82 176 163 54 61 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 83 29 

clinical_engagement 
diagnosis 
demography 
74 new agents 
154 
disease_progression 
H-positive risk:  625 672 82 1107 399 78 1173 417 162 59 173 53 
H-negative risk:  672 625 1173 1107 417 399 78 82 173 162 53 59 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 82 28 

clinical_engagement 
diagnosis 
demography 
74 new agents 
155 
disease_progression 
H-positive risk:  627 677 82 1099 397 80 1172 419 161 61 174 51 
H-negative risk:  677 627 1172 1099 419 397 80 82 174 161 51 61 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 81 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
156 
disease_progression 
H-positive risk:  623 674 82 1106 395 83 1171 421 163 59 172 51 
H-negative risk:  674 623 1171 1106 421 395 83 82 172 163 51 59 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 83 27 

clinical_engagement 
diagnosis 
demography 
80 new agents 
157 
disease_progression 
H-positive risk:  634 673 86 1103 394 83 1168 414 166 59 170 50 
H-negative risk:  673 634 1168 1103 414 394 83 86 170 166 50 59 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 82 29 

clinical_engagement 
diagnosis 
demography 
76 new agents 
158 
disease_progression 
H-positive risk:  630 668 87 1103 407 82 1158 423 162 62 165 53 
H-negative risk:  668 630 1158 1103 423 407 82 87 165 162 53 62 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 83 28 

clinical_engagement 
diagnosis 
demography 
81 new agents 
159 
disease_progression 
H-positive risk:  622 673 88 1102 403 84 1155 430 160 63 165 55 
H-negative risk:  673 622 1155 1102 430 403 84 88 165 160 55 63 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 84 29 

clinical_engagement 
diagnosis 
demography 
59 new agents 
160 
disease_progression 
H-positive risk:  621 674 88 1106 399 81 1155 428 162 64 168 54 
H-negative risk:  674 621 1155 1106 428 399 81 88 168 162 54 64 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 89 29 

clinical_engagement 
diagnosis 
demography 
75 new agents 
161 
disease_progression 
H-positive risk:  620 679 86 1109 398 81 1150 431 161 62 168 55 
H-negative risk:  679 620 1150 1109 431 398 81 86 168 161 55 62 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 89 29 

clinical_engagement 
diagnosis 
demography 
70 new agents 
162 
disease_progression 
H-positive risk:  625 679 87 1113 399 85 1138 434 161 60 165 54 
H-negative risk:  679 625 1138 1113 434 399 85 87 165 161 54 60 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 90 28 

clinical_engagement 
diagnosis 
demography 
68 new agents 
163 
disease_progression 
H-positive risk:  629 676 85 1114 389 86 1136 438 166 60 168 53 
H-negative risk:  676 629 1136 1114 438 389 86 85 168 166 53 60 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 86 30 

clinical_engagement 
diagnosis 
demography 
83 new agents 
164 
disease_progression 
H-positive risk:  624 677 84 1123 391 89 1133 435 165 59 169 51 
H-negative risk:  677 624 1133 1123 435 391 89 84 169 165 51 59 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 88 29 

clinical_engagement 
diagnosis 
demography 
58 new agents 
165 
disease_progression 
H-positive risk:  624 681 87 1117 390 91 1128 440 165 56 169 52 
H-negative risk:  681 624 1128 1117 440 390 91 87 169 165 52 56 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 87 30 

clinical_engagement 
diagnosis 
demography 
90 new agents 
166 
disease_progression 
H-positive risk:  626 680 83 1134 382 89 1139 427 165 56 169 50 
H-negative risk:  680 626 1139 1134 427 382 89 83 169 165 50 56 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 88 30 

clinical_engagement 
diagnosis 
demography 
81 new agents 
167 
disease_progression 
H-positive risk:  636 675 85 1139 380 89 1143 417 164 54 165 53 
H-negative risk:  675 636 1143 1139 417 380 89 85 165 164 53 54 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 90 31 

clinical_engagement 
diagnosis 
demography 
67 new agents 
168 
disease_progression 
H-positive risk:  639 672 85 1135 384 87 1139 422 161 57 164 55 
H-negative risk:  672 639 1139 1135 422 384 87 85 164 161 55 57 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 87 31 

clinical_engagement 
diagnosis 
demography 
58 new agents 
169 
disease_progression 
H-positive risk:  635 672 83 1136 387 89 1134 429 161 56 164 54 
H-negative risk:  672 635 1134 1136 429 387 89 83 164 161 54 56 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 87 33 

clinical_engagement 
diagnosis 
demography 
98 new agents 
170 
disease_progression 
H-positive risk:  634 672 84 1126 396 91 1138 429 156 56 164 54 
H-negative risk:  672 634 1138 1126 429 396 91 84 164 156 54 56 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 91 31 

clinical_engagement 
diagnosis 
demography 
93 new agents 
171 
disease_progression 
H-positive risk:  635 670 84 1128 396 91 1138 432 155 55 163 53 
H-negative risk:  670 635 1138 1128 432 396 91 84 163 155 53 55 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 92 30 

clinical_engagement 
diagnosis 
demography 
84 new agents 
172 
disease_progression 
H-positive risk:  638 671 85 1122 393 92 1145 429 155 54 161 55 
H-negative risk:  671 638 1145 1122 429 393 92 85 161 155 55 54 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 90 30 

clinical_engagement 
diagnosis 
demography 
67 new agents 
173 
disease_progression 
H-positive risk:  635 670 85 1119 387 90 1151 432 157 53 159 62 
H-negative risk:  670 635 1151 1119 432 387 90 85 159 157 62 53 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 90 30 

clinical_engagement 
diagnosis 
demography 
98 new agents 
174 
disease_progression 
H-positive risk:  640 670 88 1119 382 87 1158 430 156 51 161 58 
H-negative risk:  670 640 1158 1119 430 382 87 88 161 156 58 51 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 91 30 

clinical_engagement 
diagnosis 
demography 
70 new agents 
175 
disease_progression 
H-positive risk:  640 671 90 1128 380 87 1149 428 156 50 164 57 
H-negative risk:  671 640 1149 1128 428 380 87 90 164 156 57 50 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 90 30 

clinical_engagement 
diagnosis 
demography 
86 new agents 
176 
disease_progression 
H-positive risk:  638 678 88 1126 379 89 1152 426 157 50 161 56 
H-negative risk:  678 638 1152 1126 426 379 89 88 161 157 56 50 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 91 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
177 
disease_progression 
H-positive risk:  646 672 87 1130 382 88 1140 430 158 47 162 58 
H-negative risk:  672 646 1140 1130 430 382 88 87 162 158 58 47 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 93 26 

clinical_engagement 
diagnosis 
demography 
79 new agents 
178 
disease_progression 
H-positive risk:  650 665 87 1139 382 88 1136 431 157 47 158 60 
H-negative risk:  665 650 1136 1139 431 382 88 87 158 157 60 47 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 91 26 

clinical_engagement 
diagnosis 
demography 
79 new agents 
179 
disease_progression 
H-positive risk:  652 664 87 1131 389 90 1141 432 157 44 156 57 
H-negative risk:  664 652 1141 1131 432 389 90 87 156 157 57 44 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 92 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
180 
disease_progression 
H-positive risk:  656 660 85 1134 389 88 1146 429 155 45 157 56 
H-negative risk:  660 656 1146 1134 429 389 88 85 157 155 56 45 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 91 28 

clinical_engagement 
diagnosis 
demography 
83 new agents 
181 
disease_progression 
H-positive risk:  660 663 82 1135 390 88 1147 424 155 43 157 56 
H-negative risk:  663 660 1147 1135 424 390 88 82 157 155 56 43 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 90 28 

clinical_engagement 
diagnosis 
demography 
84 new agents 
182 
disease_progression 
H-positive risk:  660 666 80 1125 406 85 1138 431 148 47 157 57 
H-negative risk:  666 660 1138 1125 431 406 85 80 157 148 57 47 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 91 28 

clinical_engagement 
diagnosis 
demography 
84 new agents 
183 
disease_progression 
H-positive risk:  664 666 81 1122 402 86 1144 430 146 47 157 55 
H-negative risk:  666 664 1144 1122 430 402 86 81 157 146 55 47 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 90 29 

clinical_engagement 
diagnosis 
demography 
70 new agents 
184 
disease_progression 
H-positive risk:  668 667 83 1119 408 88 1142 425 145 45 157 53 
H-negative risk:  667 668 1142 1119 425 408 88 83 157 145 53 45 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 90 28 

clinical_engagement 
diagnosis 
demography 
78 new agents 
185 
disease_progression 
H-positive risk:  664 668 82 1119 403 91 1160 415 146 46 157 49 
H-negative risk:  668 664 1160 1119 415 403 91 82 157 146 49 46 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 88 29 

clinical_engagement 
diagnosis 
demography 
91 new agents 
186 
disease_progression 
H-positive risk:  665 677 79 1129 400 89 1152 419 140 45 159 46 
H-negative risk:  677 665 1152 1129 419 400 89 79 159 140 46 45 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 89 29 

clinical_engagement 
diagnosis 
demography 
80 new agents 
187 
disease_progression 
H-positive risk:  675 678 81 1119 398 88 1152 416 143 43 161 46 
H-negative risk:  678 675 1152 1119 416 398 88 81 161 143 46 43 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 90 30 

clinical_engagement 
diagnosis 
demography 
66 new agents 
188 
disease_progression 
H-positive risk:  684 676 82 1118 392 87 1149 420 141 43 159 49 
H-negative risk:  676 684 1149 1118 420 392 87 82 159 141 49 43 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 91 31 

clinical_engagement 
diagnosis 
demography 
75 new agents 
189 
disease_progression 
H-positive risk:  686 671 80 1122 387 90 1149 423 138 46 161 47 
H-negative risk:  671 686 1149 1122 423 387 90 80 161 138 47 46 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 96 30 

clinical_engagement 
diagnosis 
demography 
81 new agents 
190 
disease_progression 
H-positive risk:  680 675 79 1126 380 90 1144 427 140 45 165 49 
H-negative risk:  675 680 1144 1126 427 380 90 79 165 140 49 45 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 94 31 

clinical_engagement 
diagnosis 
demography 
67 new agents 
191 
disease_progression 
H-positive risk:  686 664 79 1142 378 91 1133 428 138 46 166 49 
H-negative risk:  664 686 1133 1142 428 378 91 79 166 138 49 46 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 93 31 

clinical_engagement 
diagnosis 
demography 
58 new agents 
192 
disease_progression 
H-positive risk:  681 662 79 1154 366 91 1134 432 138 47 168 48 
H-negative risk:  662 681 1134 1154 432 366 91 79 168 138 48 47 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 92 30 

clinical_engagement 
diagnosis 
demography 
74 new agents 
193 
disease_progression 
H-positive risk:  680 672 78 1148 376 92 1132 427 138 43 168 46 
H-negative risk:  672 680 1132 1148 427 376 92 78 168 138 46 43 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 95 28 

clinical_engagement 
diagnosis 
demography 
91 new agents 
194 
disease_progression 
H-positive risk:  684 667 79 1140 381 91 1134 431 136 44 166 47 
H-negative risk:  667 684 1134 1140 431 381 91 79 166 136 47 44 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 96 27 

clinical_engagement 
diagnosis 
demography 
76 new agents 
195 
disease_progression 
H-positive risk:  677 668 80 1138 381 94 1131 440 133 45 167 46 
H-negative risk:  668 677 1131 1138 440 381 94 80 167 133 46 45 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 98 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
196 
disease_progression 
H-positive risk:  682 662 83 1140 385 94 1124 440 130 46 169 45 
H-negative risk:  662 682 1124 1140 440 385 94 83 169 130 45 46 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 97 26 

clinical_engagement 
diagnosis 
demography 
79 new agents 
197 
disease_progression 
H-positive risk:  682 665 84 1132 381 95 1127 442 131 45 169 47 
H-negative risk:  665 682 1127 1132 442 381 95 84 169 131 47 45 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 95 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
198 
disease_progression 
H-positive risk:  675 666 84 1122 388 94 1132 442 133 47 170 47 
H-negative risk:  666 675 1132 1122 442 388 94 84 170 133 47 47 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 91 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
199 
disease_progression 
H-positive risk:  682 661 84 1123 384 90 1126 445 140 45 172 48 
H-negative risk:  661 682 1126 1123 445 384 90 84 172 140 48 45 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 90 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
200 
disease_progression 
H-positive risk:  682 662 82 1120 388 92 1121 446 140 47 172 48 
H-negative risk:  662 682 1121 1120 446 388 92 82 172 140 48 47 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 91 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
201 
disease_progression 
H-positive risk:  690 655 82 1127 387 91 1116 441 139 50 174 48 
H-negative risk:  655 690 1116 1127 441 387 91 82 174 139 48 50 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
202 
disease_progression 
H-positive risk:  690 651 82 1135 390 89 1105 441 140 53 176 48 
H-negative risk:  651 690 1105 1135 441 390 89 82 176 140 48 53 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 93 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
203 
disease_progression 
H-positive risk:  686 656 77 1125 400 90 1104 436 145 53 179 49 
H-negative risk:  656 686 1104 1125 436 400 90 77 179 145 49 53 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 93 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
204 
disease_progression 
H-positive risk:  685 658 81 1117 403 88 1109 433 146 52 180 48 
H-negative risk:  658 685 1109 1117 433 403 88 81 180 146 48 52 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 90 25 

clinical_engagement 
diagnosis 
demography 
87 new agents 
205 
disease_progression 
H-positive risk:  696 658 83 1115 403 88 1103 430 147 53 176 48 
H-negative risk:  658 696 1103 1115 430 403 88 83 176 147 48 53 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 91 26 

clinical_engagement 
diagnosis 
demography 
95 new agents 
206 
disease_progression 
H-positive risk:  691 664 82 1099 411 88 1092 438 150 56 180 49 
H-negative risk:  664 691 1092 1099 438 411 88 82 180 150 49 56 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 90 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
207 
disease_progression 
H-positive risk:  688 666 78 1096 421 91 1091 434 148 54 181 52 
H-negative risk:  666 688 1091 1096 434 421 91 78 181 148 52 54 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 88 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
208 
disease_progression 
H-positive risk:  690 672 79 1098 418 92 1082 428 149 54 182 56 
H-negative risk:  672 690 1082 1098 428 418 92 79 182 149 56 54 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
209 
disease_progression 
H-positive risk:  691 682 79 1090 413 92 1086 426 147 57 180 57 
H-negative risk:  682 691 1086 1090 426 413 92 79 180 147 57 57 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
210 
disease_progression 
H-positive risk:  696 686 79 1098 404 91 1081 425 146 57 180 57 
H-negative risk:  686 696 1081 1098 425 404 91 79 180 146 57 57 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 86 24 

clinical_engagement 
diagnosis 
demography 
81 new agents 
211 
disease_progression 
H-positive risk:  700 685 81 1087 408 92 1084 419 149 57 181 57 
H-negative risk:  685 700 1084 1087 419 408 92 81 181 149 57 57 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
212 
disease_progression 
H-positive risk:  703 682 82 1083 408 93 1084 419 149 59 183 55 
H-negative risk:  682 703 1084 1083 419 408 93 82 183 149 55 59 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 84 27 

clinical_engagement 
diagnosis 
demography 
84 new agents 
213 
disease_progression 
H-positive risk:  705 686 82 1083 407 89 1080 425 148 56 184 55 
H-negative risk:  686 705 1080 1083 425 407 89 82 184 148 55 56 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
60 new agents 
214 
disease_progression 
H-positive risk:  702 691 81 1083 408 87 1085 420 149 56 182 56 
H-negative risk:  691 702 1085 1083 420 408 87 81 182 149 56 56 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 85 27 

clinical_engagement 
diagnosis 
demography 
79 new agents 
215 
disease_progression 
H-positive risk:  710 690 83 1076 410 87 1077 425 149 58 179 56 
H-negative risk:  690 710 1077 1076 425 410 87 83 179 149 56 58 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 84 27 

clinical_engagement 
diagnosis 
demography 
69 new agents 
216 
disease_progression 
H-positive risk:  710 695 83 1066 413 89 1084 413 149 61 179 58 
H-negative risk:  695 710 1084 1066 413 413 89 83 179 149 58 61 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 85 28 

clinical_engagement 
diagnosis 
demography 
82 new agents 
217 
disease_progression 
H-positive risk:  713 696 83 1050 419 86 1083 424 149 61 177 59 
H-negative risk:  696 713 1083 1050 424 419 86 83 177 149 59 61 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
94 new agents 
218 
disease_progression 
H-positive risk:  718 694 88 1045 418 86 1081 424 153 60 176 57 
H-negative risk:  694 718 1081 1045 424 418 86 88 176 153 57 60 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
84 new agents 
219 
disease_progression 
H-positive risk:  718 706 87 1046 422 86 1062 426 153 61 175 58 
H-negative risk:  706 718 1062 1046 426 422 86 87 175 153 58 61 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
93 new agents 
220 
disease_progression 
H-positive risk:  725 700 87 1050 422 85 1053 435 156 56 172 59 
H-negative risk:  700 725 1053 1050 435 422 85 87 172 156 59 56 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
221 
disease_progression 
H-positive risk:  724 702 89 1053 422 86 1051 432 157 56 171 57 
H-negative risk:  702 724 1051 1053 432 422 86 89 171 157 57 56 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
84 new agents 
222 
disease_progression 
H-positive risk:  725 705 95 1060 414 86 1047 427 155 58 170 58 
H-negative risk:  705 725 1047 1060 427 414 86 95 170 155 58 58 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
223 
disease_progression 
H-positive risk:  729 704 96 1062 407 86 1049 426 155 61 168 57 
H-negative risk:  704 729 1049 1062 426 407 86 96 168 155 57 61 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
85 new agents 
224 
disease_progression 
H-positive risk:  720 703 98 1055 421 85 1043 427 152 62 172 62 
H-negative risk:  703 720 1043 1055 427 421 85 98 172 152 62 62 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
225 
disease_progression 
H-positive risk:  728 702 99 1057 415 84 1040 428 153 60 172 62 
H-negative risk:  702 728 1040 1057 428 415 84 99 172 153 62 60 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 86 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
226 
disease_progression 
H-positive risk:  728 698 100 1047 418 86 1041 432 153 63 170 64 
H-negative risk:  698 728 1041 1047 432 418 86 100 170 153 64 63 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
65 new agents 
227 
disease_progression 
H-positive risk:  726 697 100 1055 409 87 1043 437 151 62 171 62 
H-negative risk:  697 726 1043 1055 437 409 87 100 171 151 62 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
228 
disease_progression 
H-positive risk:  732 698 101 1052 402 88 1038 435 152 67 171 64 
H-negative risk:  698 732 1038 1052 435 402 88 101 171 152 64 67 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
229 
disease_progression 
H-positive risk:  729 699 101 1045 410 89 1031 444 151 67 167 67 
H-negative risk:  699 729 1031 1045 444 410 89 101 167 151 67 67 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
230 
disease_progression 
H-positive risk:  732 696 101 1055 399 88 1035 442 150 69 167 66 
H-negative risk:  696 732 1035 1055 442 399 88 101 167 150 66 69 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
86 new agents 
231 
disease_progression 
H-positive risk:  736 701 102 1052 395 91 1028 434 149 73 168 71 
H-negative risk:  701 736 1028 1052 434 395 91 102 168 149 71 73 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
232 
disease_progression 
H-positive risk:  727 707 103 1050 393 93 1031 436 148 73 166 73 
H-negative risk:  707 727 1031 1050 436 393 93 103 166 148 73 73 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
68 new agents 
233 
disease_progression 
H-positive risk:  730 706 104 1052 384 91 1034 443 145 74 165 72 
H-negative risk:  706 730 1034 1052 443 384 91 104 165 145 72 74 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
68 new agents 
234 
disease_progression 
H-positive risk:  721 709 104 1053 390 89 1028 450 146 75 164 71 
H-negative risk:  709 721 1028 1053 450 390 89 104 164 146 71 75 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
235 
disease_progression 
H-positive risk:  714 714 105 1053 394 86 1039 448 147 72 161 67 
H-negative risk:  714 714 1039 1053 448 394 86 105 161 147 67 72 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
236 
disease_progression 
H-positive risk:  715 709 108 1058 394 86 1033 453 145 73 158 68 
H-negative risk:  709 715 1033 1058 453 394 86 108 158 145 68 73 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
237 
disease_progression 
H-positive risk:  714 715 107 1053 397 88 1028 460 142 70 154 72 
H-negative risk:  715 714 1028 1053 460 397 88 107 154 142 72 70 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
238 
disease_progression 
H-positive risk:  728 719 108 1056 386 90 1018 457 142 70 153 73 
H-negative risk:  719 728 1018 1056 457 386 90 108 153 142 73 70 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
239 
disease_progression 
H-positive risk:  730 716 109 1052 396 90 1013 457 142 70 150 75 
H-negative risk:  716 730 1013 1052 457 396 90 109 150 142 75 70 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
240 
disease_progression 
H-positive risk:  731 719 107 1049 404 91 1015 447 137 71 154 75 
H-negative risk:  719 731 1015 1049 447 404 91 107 154 137 75 71 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
241 
disease_progression 
H-positive risk:  736 724 110 1036 417 90 997 451 136 75 151 77 
H-negative risk:  724 736 997 1036 451 417 90 110 151 136 77 75 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
64 new agents 
242 
disease_progression 
H-positive risk:  737 722 108 1031 420 93 996 452 138 74 151 78 
H-negative risk:  722 737 996 1031 452 420 93 108 151 138 78 74 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
65 new agents 
243 
disease_progression 
H-positive risk:  732 711 109 1042 423 97 996 456 137 71 151 75 
H-negative risk:  711 732 996 1042 456 423 97 109 151 137 75 71 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
244 
disease_progression 
H-positive risk:  720 716 110 1043 430 98 996 458 137 70 148 74 
H-negative risk:  716 720 996 1043 458 430 98 110 148 137 74 70 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
245 
disease_progression 
H-positive risk:  720 719 111 1038 427 94 1005 451 142 68 150 75 
H-negative risk:  719 720 1005 1038 451 427 94 111 150 142 75 68 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 90 24 

clinical_engagement 
diagnosis 
demography 
81 new agents 
246 
disease_progression 
H-positive risk:  716 717 108 1047 424 95 999 454 143 66 157 74 
H-negative risk:  717 716 999 1047 454 424 95 108 157 143 74 66 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
74 new agents 
247 
disease_progression 
H-positive risk:  711 717 105 1056 426 96 998 452 140 68 158 73 
H-negative risk:  717 711 998 1056 452 426 96 105 158 140 73 68 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
248 
disease_progression 
H-positive risk:  710 722 108 1055 418 97 999 454 139 68 157 73 
H-negative risk:  722 710 999 1055 454 418 97 108 157 139 73 68 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
249 
disease_progression 
H-positive risk:  705 729 109 1052 414 98 1003 456 138 66 159 71 
H-negative risk:  729 705 1003 1052 456 414 98 109 159 138 71 66 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
250 
disease_progression 
H-positive risk:  697 720 110 1054 417 98 1017 453 138 67 157 72 
H-negative risk:  720 697 1017 1054 453 417 98 110 157 138 72 67 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
251 
disease_progression 
H-positive risk:  699 714 110 1063 418 100 1014 446 142 70 151 73 
H-negative risk:  714 699 1014 1063 446 418 100 110 151 142 73 70 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 72 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
252 
disease_progression 
H-positive risk:  704 717 112 1053 415 101 1015 444 143 71 152 73 
H-negative risk:  717 704 1015 1053 444 415 101 112 152 143 73 71 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 70 26 

clinical_engagement 
diagnosis 
demography 
102 new agents 
253 
disease_progression 
H-positive risk:  708 709 111 1050 414 101 1025 448 141 68 151 74 
H-negative risk:  709 708 1025 1050 448 414 101 111 151 141 74 68 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 71 26 

clinical_engagement 
diagnosis 
demography 
81 new agents 
254 
disease_progression 
H-positive risk:  709 709 108 1061 410 101 1025 441 139 70 153 74 
H-negative risk:  709 709 1025 1061 441 410 101 108 153 139 74 70 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
255 
disease_progression 
H-positive risk:  708 707 107 1052 415 100 1023 448 141 69 159 71 
H-negative risk:  707 708 1023 1052 448 415 100 107 159 141 71 69 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 68 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
256 
disease_progression 
H-positive risk:  705 701 107 1050 424 102 1027 448 140 69 153 74 
H-negative risk:  701 705 1027 1050 448 424 102 107 153 140 74 69 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 71 25 

clinical_engagement 
diagnosis 
demography 
87 new agents 
257 
disease_progression 
H-positive risk:  713 695 108 1061 428 106 1021 437 142 67 151 71 
H-negative risk:  695 713 1021 1061 437 428 106 108 151 142 71 67 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 72 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
258 
disease_progression 
H-positive risk:  712 701 108 1063 426 110 1019 435 142 65 148 71 
H-negative risk:  701 712 1019 1063 435 426 110 108 148 142 71 65 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 73 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
259 
disease_progression 
H-positive risk:  719 700 108 1075 418 110 1023 423 139 67 145 73 
H-negative risk:  700 719 1023 1075 423 418 110 108 145 139 73 67 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 73 28 

clinical_engagement 
diagnosis 
demography 
90 new agents 
260 
disease_progression 
H-positive risk:  721 707 108 1082 408 111 1023 423 136 63 146 72 
H-negative risk:  707 721 1023 1082 423 408 111 108 146 136 72 63 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 74 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
261 
disease_progression 
H-positive risk:  722 707 107 1089 407 109 1025 420 134 61 147 72 
H-negative risk:  707 722 1025 1089 420 407 109 107 147 134 72 61 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 75 28 

clinical_engagement 
diagnosis 
demography 
75 new agents 
262 
disease_progression 
H-positive risk:  730 698 107 1095 409 107 1021 418 136 61 149 69 
H-negative risk:  698 730 1021 1095 418 409 107 107 149 136 69 61 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
59 new agents 
263 
disease_progression 
H-positive risk:  726 697 109 1086 406 106 1031 421 136 61 151 70 
H-negative risk:  697 726 1031 1086 421 406 106 109 151 136 70 61 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
264 
disease_progression 
H-positive risk:  719 694 109 1093 402 108 1042 416 132 61 152 72 
H-negative risk:  694 719 1042 1093 416 402 108 109 152 132 72 61 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 69 24 

clinical_engagement 
diagnosis 
demography 
64 new agents 
265 
disease_progression 
H-positive risk:  717 685 109 1100 402 106 1052 414 134 57 153 71 
H-negative risk:  685 717 1052 1100 414 402 106 109 153 134 71 57 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 70 25 

clinical_engagement 
diagnosis 
demography 
95 new agents 
266 
disease_progression 
H-positive risk:  718 690 111 1097 405 107 1047 414 131 60 151 69 
H-negative risk:  690 718 1047 1097 414 405 107 111 151 131 69 60 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 67 26 

clinical_engagement 
diagnosis 
demography 
84 new agents 
267 
disease_progression 
H-positive risk:  715 689 111 1097 414 102 1054 411 132 58 150 67 
H-negative risk:  689 715 1054 1097 411 414 102 111 150 132 67 58 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 69 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
268 
disease_progression 
H-positive risk:  713 701 111 1097 405 107 1045 412 132 57 150 70 
H-negative risk:  701 713 1045 1097 412 405 107 111 150 132 70 57 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 72 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
269 
disease_progression 
H-positive risk:  710 703 107 1094 399 107 1052 412 133 59 156 68 
H-negative risk:  703 710 1052 1094 412 399 107 107 156 133 68 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
84 new agents 
270 
disease_progression 
H-positive risk:  701 698 107 1095 405 107 1056 410 136 57 157 71 
H-negative risk:  698 701 1056 1095 410 405 107 107 157 136 71 57 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
271 
disease_progression 
H-positive risk:  694 696 106 1098 409 104 1061 408 137 58 156 73 
H-negative risk:  696 694 1061 1098 408 409 104 106 156 137 73 58 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
272 
disease_progression 
H-positive risk:  698 691 105 1101 398 106 1059 415 138 57 162 70 
H-negative risk:  691 698 1059 1101 415 398 106 105 162 138 70 57 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
85 new agents 
273 
disease_progression 
H-positive risk:  693 691 105 1109 393 105 1071 405 138 56 164 70 
H-negative risk:  691 693 1071 1109 405 393 105 105 164 138 70 56 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
81 new agents 
274 
disease_progression 
H-positive risk:  694 692 104 1107 396 107 1069 407 141 55 159 69 
H-negative risk:  692 694 1069 1107 407 396 107 104 159 141 69 55 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
275 
disease_progression 
H-positive risk:  691 694 104 1094 402 106 1073 411 141 53 160 71 
H-negative risk:  694 691 1073 1094 411 402 106 104 160 141 71 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
87 new agents 
276 
disease_progression 
H-positive risk:  694 698 108 1091 409 100 1068 409 142 52 157 72 
H-negative risk:  698 694 1068 1091 409 409 100 108 157 142 72 52 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 78 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
277 
disease_progression 
H-positive risk:  691 689 109 1093 415 99 1075 412 138 54 154 71 
H-negative risk:  689 691 1075 1093 412 415 99 109 154 138 71 54 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
278 
disease_progression 
H-positive risk:  692 685 108 1095 407 99 1086 409 137 54 155 73 
H-negative risk:  685 692 1086 1095 409 407 99 108 155 137 73 54 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
279 
disease_progression 
H-positive risk:  699 677 109 1101 410 101 1079 411 136 54 153 70 
H-negative risk:  677 699 1079 1101 411 410 101 109 153 136 70 54 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
280 
disease_progression 
H-positive risk:  705 678 106 1103 408 100 1066 420 137 54 153 70 
H-negative risk:  678 705 1066 1103 420 408 100 106 153 137 70 54 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
281 
disease_progression 
H-positive risk:  716 680 108 1102 410 101 1061 413 130 56 155 68 
H-negative risk:  680 716 1061 1102 413 410 101 108 155 130 68 56 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
282 
disease_progression 
H-positive risk:  713 684 107 1104 409 102 1063 406 127 59 156 70 
H-negative risk:  684 713 1063 1104 406 409 102 107 156 127 70 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
283 
disease_progression 
H-positive risk:  718 681 107 1117 406 103 1055 402 127 58 155 71 
H-negative risk:  681 718 1055 1117 402 406 103 107 155 127 71 58 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
81 new agents 
284 
disease_progression 
H-positive risk:  716 685 107 1110 405 103 1056 406 127 58 156 71 
H-negative risk:  685 716 1056 1110 406 405 103 107 156 127 71 58 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
85 new agents 
285 
disease_progression 
H-positive risk:  708 692 107 1110 406 103 1068 400 123 59 154 70 
H-negative risk:  692 708 1068 1110 400 406 103 107 154 123 70 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
286 
disease_progression 
H-positive risk:  709 686 108 1122 406 102 1065 395 126 61 152 68 
H-negative risk:  686 709 1065 1122 395 406 102 108 152 126 68 61 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
79 new agents 
287 
disease_progression 
H-positive risk:  706 686 107 1118 409 103 1080 384 125 61 151 70 
H-negative risk:  686 706 1080 1118 384 409 103 107 151 125 70 61 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
288 
disease_progression 
H-positive risk:  711 680 106 1106 413 103 1083 389 126 59 152 72 
H-negative risk:  680 711 1083 1106 389 413 103 106 152 126 72 59 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 73 26 

clinical_engagement 
diagnosis 
demography 
82 new agents 
289 
disease_progression 
H-positive risk:  707 686 106 1097 421 107 1092 379 128 61 147 69 
H-negative risk:  686 707 1092 1097 379 421 107 106 147 128 69 61 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 74 27 

clinical_engagement 
diagnosis 
demography 
69 new agents 
290 
disease_progression 
H-positive risk:  704 692 107 1103 415 109 1087 379 131 61 146 66 
H-negative risk:  692 704 1087 1103 379 415 109 107 146 131 66 61 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 77 27 

clinical_engagement 
diagnosis 
demography 
79 new agents 
291 
disease_progression 
H-positive risk:  707 706 110 1094 406 106 1082 382 133 62 150 62 
H-negative risk:  706 707 1082 1094 382 406 106 110 150 133 62 62 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 78 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
292 
disease_progression 
H-positive risk:  713 705 112 1091 401 105 1088 380 135 61 148 61 
H-negative risk:  705 713 1088 1091 380 401 105 112 148 135 61 61 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 76 28 

clinical_engagement 
diagnosis 
demography 
61 new agents 
293 
disease_progression 
H-positive risk:  718 694 110 1093 404 107 1089 378 137 60 148 62 
H-negative risk:  694 718 1089 1093 378 404 107 110 148 137 62 60 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 76 29 

clinical_engagement 
diagnosis 
demography 
79 new agents 
294 
disease_progression 
H-positive risk:  721 700 111 1096 403 103 1077 379 142 58 145 65 
H-negative risk:  700 721 1077 1096 379 403 103 111 145 142 65 58 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 78 29 

clinical_engagement 
diagnosis 
demography 
90 new agents 
295 
disease_progression 
H-positive risk:  710 699 110 1096 408 98 1081 383 147 58 142 68 
H-negative risk:  699 710 1081 1096 383 408 98 110 142 147 68 58 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 78 27 

clinical_engagement 
diagnosis 
demography 
72 new agents 
296 
disease_progression 
H-positive risk:  707 700 108 1092 419 98 1072 386 149 58 141 70 
H-negative risk:  700 707 1072 1092 386 419 98 108 141 149 70 58 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 78 27 

clinical_engagement 
diagnosis 
demography 
70 new agents 
297 
disease_progression 
H-positive risk:  713 700 105 1092 421 98 1067 386 151 56 141 70 
H-negative risk:  700 713 1067 1092 386 421 98 105 141 151 70 56 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 75 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
298 
disease_progression 
H-positive risk:  711 701 104 1083 425 102 1075 385 152 54 142 66 
H-negative risk:  701 711 1075 1083 385 425 102 104 142 152 66 54 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 72 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
299 
disease_progression 
H-positive risk:  705 698 105 1092 422 103 1074 386 153 53 144 65 
H-negative risk:  698 705 1074 1092 386 422 103 105 144 153 65 53 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 71 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
300 
disease_progression 
H-positive risk:  698 700 104 1096 420 103 1078 391 155 49 141 65 
H-negative risk:  700 698 1078 1096 391 420 103 104 141 155 65 49 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 72 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
301 
disease_progression 
H-positive risk:  695 706 104 1093 413 101 1078 392 161 49 139 69 
H-negative risk:  706 695 1078 1093 392 413 101 104 139 161 69 49 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 73 26 

clinical_engagement 
diagnosis 
demography 
98 new agents 
302 
disease_progression 
H-positive risk:  699 706 105 1094 407 103 1077 386 165 49 139 70 
H-negative risk:  706 699 1077 1094 386 407 103 105 139 165 70 49 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
63 new agents 
303 
disease_progression 
H-positive risk:  692 704 104 1095 407 107 1086 380 164 50 138 73 
H-negative risk:  704 692 1086 1095 380 407 107 104 138 164 73 50 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
84 new agents 
304 
disease_progression 
H-positive risk:  698 710 103 1088 404 108 1079 386 161 53 139 71 
H-negative risk:  710 698 1079 1088 386 404 108 103 139 161 71 53 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
305 
disease_progression 
H-positive risk:  690 705 103 1081 415 103 1084 388 166 54 140 71 
H-negative risk:  705 690 1084 1081 388 415 103 103 140 166 71 54 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
306 
disease_progression 
H-positive risk:  698 710 102 1083 410 101 1080 385 169 53 137 72 
H-negative risk:  710 698 1080 1083 385 410 101 102 137 169 72 53 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
307 
disease_progression 
H-positive risk:  706 711 102 1074 414 101 1077 380 170 54 139 72 
H-negative risk:  711 706 1077 1074 380 414 101 102 139 170 72 54 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 71 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
308 
disease_progression 
H-positive risk:  703 721 102 1068 411 100 1078 381 169 58 139 70 
H-negative risk:  721 703 1078 1068 381 411 100 102 139 169 70 58 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 74 26 

clinical_engagement 
diagnosis 
demography 
89 new agents 
309 
disease_progression 
H-positive risk:  708 719 104 1057 408 99 1081 384 171 57 143 69 
H-negative risk:  719 708 1081 1057 384 408 99 104 143 171 69 57 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 74 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
310 
disease_progression 
H-positive risk:  708 722 103 1059 403 103 1079 381 172 57 145 68 
H-negative risk:  722 708 1079 1059 381 403 103 103 145 172 68 57 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 75 27 

clinical_engagement 
diagnosis 
demography 
63 new agents 
311 
disease_progression 
H-positive risk:  701 729 101 1059 403 105 1078 385 173 56 145 65 
H-negative risk:  729 701 1078 1059 385 403 105 101 145 173 65 56 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 76 27 

clinical_engagement 
diagnosis 
demography 
74 new agents 
312 
disease_progression 
H-positive risk:  697 726 102 1067 398 106 1079 390 172 54 144 65 
H-negative risk:  726 697 1079 1067 390 398 106 102 144 172 65 54 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 74 27 

clinical_engagement 
diagnosis 
demography 
81 new agents 
313 
disease_progression 
H-positive risk:  690 737 104 1059 397 107 1080 395 172 53 142 64 
H-negative risk:  737 690 1080 1059 395 397 107 104 142 172 64 53 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 72 27 

clinical_engagement 
diagnosis 
demography 
72 new agents 
314 
disease_progression 
H-positive risk:  688 739 106 1053 399 108 1085 395 166 54 143 64 
H-negative risk:  739 688 1085 1053 395 399 108 106 143 166 64 54 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
315 
disease_progression 
H-positive risk:  682 738 110 1058 390 110 1092 393 160 57 145 65 
H-negative risk:  738 682 1092 1058 393 390 110 110 145 160 65 57 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 72 27 

clinical_engagement 
diagnosis 
demography 
78 new agents 
316 
disease_progression 
H-positive risk:  691 741 109 1049 389 109 1094 390 160 58 145 65 
H-negative risk:  741 691 1094 1049 390 389 109 109 145 160 65 58 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 72 28 

clinical_engagement 
diagnosis 
demography 
69 new agents 
317 
disease_progression 
H-positive risk:  688 737 112 1056 382 105 1099 388 160 60 147 66 
H-negative risk:  737 688 1099 1056 388 382 105 112 147 160 66 60 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 73 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
318 
disease_progression 
H-positive risk:  683 746 114 1065 376 106 1101 382 159 56 147 65 
H-negative risk:  746 683 1101 1065 382 376 106 114 147 159 65 56 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 70 26 

clinical_engagement 
diagnosis 
demography 
82 new agents 
319 
disease_progression 
H-positive risk:  681 745 113 1070 377 108 1093 391 154 60 145 63 
H-negative risk:  745 681 1093 1070 391 377 108 113 145 154 63 60 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 71 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
320 
disease_progression 
H-positive risk:  687 745 111 1066 372 109 1099 388 154 60 145 64 
H-negative risk:  745 687 1099 1066 388 372 109 111 145 154 64 60 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 67 27 

clinical_engagement 
diagnosis 
demography 
74 new agents 
321 
disease_progression 
H-positive risk:  693 748 111 1063 369 111 1099 388 153 56 145 64 
H-negative risk:  748 693 1099 1063 388 369 111 111 145 153 64 56 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 70 28 

clinical_engagement 
diagnosis 
demography 
64 new agents 
322 
disease_progression 
H-positive risk:  695 744 109 1068 368 109 1093 394 154 56 148 62 
H-negative risk:  744 695 1093 1068 394 368 109 109 148 154 62 56 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 67 29 

clinical_engagement 
diagnosis 
demography 
74 new agents 
323 
disease_progression 
H-positive risk:  694 753 113 1067 366 106 1086 398 155 53 147 62 
H-negative risk:  753 694 1086 1067 398 366 106 113 147 155 62 53 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 68 30 

clinical_engagement 
diagnosis 
demography 
79 new agents 
324 
disease_progression 
H-positive risk:  696 755 112 1073 366 106 1078 400 155 52 145 62 
H-negative risk:  755 696 1078 1073 400 366 106 112 145 155 62 52 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 69 30 

clinical_engagement 
diagnosis 
demography 
70 new agents 
325 
disease_progression 
H-positive risk:  690 763 112 1069 366 105 1079 399 157 52 146 62 
H-negative risk:  763 690 1079 1069 399 366 105 112 146 157 62 52 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 73 30 

clinical_engagement 
diagnosis 
demography 
77 new agents 
326 
disease_progression 
H-positive risk:  688 759 110 1061 376 101 1085 398 160 52 152 58 
H-negative risk:  759 688 1085 1061 398 376 101 110 152 160 58 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 74 28 

clinical_engagement 
diagnosis 
demography 
78 new agents 
327 
disease_progression 
H-positive risk:  693 749 111 1069 372 101 1089 398 160 49 156 53 
H-negative risk:  749 693 1089 1069 398 372 101 111 156 160 53 49 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 74 28 

clinical_engagement 
diagnosis 
demography 
69 new agents 
328 
disease_progression 
H-positive risk:  691 745 108 1075 377 101 1092 392 159 49 157 54 
H-negative risk:  745 691 1092 1075 392 377 101 108 157 159 54 49 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 73 27 

clinical_engagement 
diagnosis 
demography 
85 new agents 
329 
disease_progression 
H-positive risk:  697 749 110 1075 377 101 1087 387 160 50 153 54 
H-negative risk:  749 697 1087 1075 387 377 101 110 153 160 54 50 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
63 new agents 
330 
disease_progression 
H-positive risk:  703 746 108 1079 374 101 1087 384 161 51 153 53 
H-negative risk:  746 703 1087 1079 384 374 101 108 153 161 53 51 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 71 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
331 
disease_progression 
H-positive risk:  707 747 108 1091 374 99 1069 388 163 49 148 57 
H-negative risk:  747 707 1069 1091 388 374 99 108 148 163 57 49 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
332 
disease_progression 
H-positive risk:  699 751 107 1087 382 101 1066 387 164 50 150 56 
H-negative risk:  751 699 1066 1087 387 382 101 107 150 164 56 50 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 77 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
333 
disease_progression 
H-positive risk:  690 746 108 1096 376 106 1074 385 165 50 149 55 
H-negative risk:  746 690 1074 1096 385 376 106 108 149 165 55 50 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 73 26 

clinical_engagement 
diagnosis 
demography 
84 new agents 
334 
disease_progression 
H-positive risk:  680 745 108 1094 377 108 1076 392 162 54 145 59 
H-negative risk:  745 680 1076 1094 392 377 108 108 145 162 59 54 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 72 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
335 
disease_progression 
H-positive risk:  682 745 108 1087 387 110 1072 388 159 58 146 58 
H-negative risk:  745 682 1072 1087 388 387 110 108 146 159 58 58 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 72 27 

clinical_engagement 
diagnosis 
demography 
79 new agents 
336 
disease_progression 
H-positive risk:  686 747 106 1083 391 113 1072 379 159 59 149 56 
H-negative risk:  747 686 1072 1083 379 391 113 106 149 159 56 59 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 77 27 

clinical_engagement 
diagnosis 
demography 
78 new agents 
337 
disease_progression 
H-positive risk:  691 746 106 1084 392 112 1071 379 156 59 150 54 
H-negative risk:  746 691 1071 1084 379 392 112 106 150 156 54 59 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 75 27 

clinical_engagement 
diagnosis 
demography 
60 new agents 
338 
disease_progression 
H-positive risk:  686 746 111 1072 400 112 1079 373 158 61 145 57 
H-negative risk:  746 686 1079 1072 373 400 112 111 145 158 57 61 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 78 26 

clinical_engagement 
diagnosis 
demography 
68 new agents 
339 
disease_progression 
H-positive risk:  676 744 110 1080 402 109 1079 381 162 58 143 56 
H-negative risk:  744 676 1079 1080 381 402 109 110 143 162 56 58 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 81 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
340 
disease_progression 
H-positive risk:  666 742 106 1075 410 107 1093 383 159 58 146 55 
H-negative risk:  742 666 1093 1075 383 410 107 106 146 159 55 58 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
341 
disease_progression 
H-positive risk:  665 741 106 1072 414 107 1094 382 158 57 146 58 
H-negative risk:  741 665 1094 1072 382 414 107 106 146 158 58 57 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
81 new agents 
342 
disease_progression 
H-positive risk:  658 735 103 1079 414 109 1099 385 157 56 147 58 
H-negative risk:  735 658 1099 1079 385 414 109 103 147 157 58 56 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
343 
disease_progression 
H-positive risk:  659 744 103 1074 412 108 1101 381 158 54 147 59 
H-negative risk:  744 659 1101 1074 381 412 108 103 147 158 59 54 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
344 
disease_progression 
H-positive risk:  655 746 104 1069 413 108 1100 388 161 50 147 59 
H-negative risk:  746 655 1100 1069 388 413 108 104 147 161 59 50 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
64 new agents 
345 
disease_progression 
H-positive risk:  654 740 106 1070 410 108 1095 396 164 49 146 62 
H-negative risk:  740 654 1095 1070 396 410 108 106 146 164 62 49 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
346 
disease_progression 
H-positive risk:  649 753 106 1068 410 106 1094 397 162 51 145 59 
H-negative risk:  753 649 1094 1068 397 410 106 106 145 162 59 51 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
347 
disease_progression 
H-positive risk:  649 746 106 1063 413 105 1090 411 162 52 145 58 
H-negative risk:  746 649 1090 1063 411 413 105 106 145 162 58 52 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 86 26 

clinical_engagement 
diagnosis 
demography 
82 new agents 
348 
disease_progression 
H-positive risk:  647 741 107 1066 401 105 1098 418 161 55 140 61 
H-negative risk:  741 647 1098 1066 418 401 105 107 140 161 61 55 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
349 
disease_progression 
H-positive risk:  647 736 108 1071 400 107 1094 415 160 57 141 64 
H-negative risk:  736 647 1094 1071 415 400 107 108 141 160 64 57 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
81 new agents 
350 
disease_progression 
H-positive risk:  647 734 108 1076 405 109 1091 416 152 60 141 61 
H-negative risk:  734 647 1091 1076 416 405 109 108 141 152 61 60 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
92 new agents 
351 
disease_progression 
H-positive risk:  650 741 109 1072 397 104 1089 416 156 65 141 60 
H-negative risk:  741 650 1089 1072 416 397 104 109 141 156 60 65 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
352 
disease_progression 
H-positive risk:  650 731 110 1075 405 104 1086 414 160 63 143 59 
H-negative risk:  731 650 1086 1075 414 405 104 110 143 160 59 63 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 87 20 

clinical_engagement 
diagnosis 
demography 
70 new agents 
353 
disease_progression 
H-positive risk:  647 730 108 1075 407 106 1084 420 160 62 141 60 
H-negative risk:  730 647 1084 1075 420 407 106 108 141 160 60 62 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
83 new agents 
354 
disease_progression 
H-positive risk:  643 728 108 1072 405 107 1088 427 159 62 140 61 
H-negative risk:  728 643 1088 1072 427 405 107 108 140 159 61 62 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 84 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
355 
disease_progression 
H-positive risk:  646 724 108 1077 399 106 1087 429 163 63 140 58 
H-negative risk:  724 646 1087 1077 429 399 106 108 140 163 58 63 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 85 19 

clinical_engagement 
diagnosis 
demography 
79 new agents 
356 
disease_progression 
H-positive risk:  639 723 110 1079 403 107 1082 428 165 64 142 58 
H-negative risk:  723 639 1082 1079 428 403 107 110 142 165 58 64 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 85 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
357 
disease_progression 
H-positive risk:  641 719 111 1087 404 107 1082 424 164 63 142 56 
H-negative risk:  719 641 1082 1087 424 404 107 111 142 164 56 63 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 89 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
358 
disease_progression 
H-positive risk:  637 717 113 1089 401 105 1089 421 167 65 141 55 
H-negative risk:  717 637 1089 1089 421 401 105 113 141 167 55 65 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 88 19 

clinical_engagement 
diagnosis 
demography 
67 new agents 
359 
disease_progression 
H-positive risk:  641 711 110 1095 407 104 1082 423 161 68 143 55 
H-negative risk:  711 641 1082 1095 423 407 104 110 143 161 55 68 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 91 19 

clinical_engagement 
diagnosis 
demography 
95 new agents 
360 
disease_progression 
H-positive risk:  646 717 108 1091 406 104 1082 418 163 66 143 56 
H-negative risk:  717 646 1082 1091 418 406 104 108 143 163 56 66 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 91 17 

clinical_engagement 
diagnosis 
demography 
82 new agents 
Time difference of 17.84432 mins
This is task 28
